What is Vericel's cumulative cost basis?

Vericel (VCEL) reported cumulative cost basis of $101.5M in Q1 2026.

How has Vericel's cumulative cost basis changed year-over-year?

Vericel's cumulative cost basis increased by 22.9% year-over-year, from $82.62M to $101.5M.

What is the long-term trend for Vericel's cumulative cost basis?

Over 5 years (2020 to 2025), Vericel's cumulative cost basis has grown at a 8.3% compound annual growth rate (CAGR), from $66.27M to $98.53M.

Vericel VCEL Cumulative Cost Basis

Cumulative Cost Basis at other companies

StrykerSYK

——

Globus MedicalGMED

——

Johnson & JohnsonJNJ

——

Other financials

Income statement

See full

Revenue$68.4M+30.1%

Gross profit$49.3M+35.8%

Operating income-$8.1M+37.0%

Net income-$6.3M+44.0%

EPS (diluted)-$0.12+47.8%

Balance sheet

See full

Cash & equivalents$109.3M+37.1%

Total debt$95.0M-4.6%

Total equity$356.2M+20.6%

Total assets$485.6M+14.4%

Cash flow

See full

Operating cash flow$16.4M+148%

CapEx$1.3M-91.2%

Free cash flow$15.1M+299%

Valuation

See full

Market cap$2.13B-26.8%

Profitability

See full

Gross margin74.8%+2.3pp

Operating margin5.4%+4.6pp

Net margin7.3%+6.1pp

FCF margin16.3%—

Returns & leverage

See full

Return on equity6.6%+5.5pp

Debt / equity0.3×-0.1×

Current ratio5.2×+0.2×

Where this comes from

Reported directly by Vericel in its filing.

Tagged under the XBRL concept us-gaap:AvailableForSaleDebtSecuritiesAmortizedCostBasis.

The official record: Vericel’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vericel's cumulative cost basis.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Vericel's cumulative cost basis?: Vericel (VCEL) reported cumulative cost basis of $101.5M in Q1 2026.
How has Vericel's cumulative cost basis changed year-over-year?: Vericel's cumulative cost basis increased by 22.9% year-over-year, from $82.62M to $101.5M.
What is the long-term trend for Vericel's cumulative cost basis?: Over 5 years (2020 to 2025), Vericel's cumulative cost basis has grown at a 8.3% compound annual growth rate (CAGR), from $66.27M to $98.53M.